BAWC
ABBV icon

Boyce & Associates Wealth Consulting’s AbbVie ABBV Stock Holding History

Boyce & Associates Wealth Consulting’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$365K Buy
1,396
+1
+0.1% +$256 0.22% 60
2026
Q2 		$351K Buy
1,395
+10
+0.7% +$2.15K 0.24% 59
2026
Q1 		$301K Buy
1,385
+153
+12% +$33.9K 0.23% 62
2025
Q4 		$282K Sell
1,232
-42
-3% -$9.57K 0.24% 59
2025
Q3 		$295K Buy
1,274
+10
+0.8% +$2.04K 0.24% 56
2025
Q2 		$235K Buy
1,264
+11
+0.9% +$2.04K 0.21% 66
2025
Q1 		$263K Buy
1,253
+1
+0.1% +$194 0.26% 57
2024
Q4 		$222K Buy
1,252
+1
+0.1% +$184 0.23% 66
2024
Q3 		$247K Buy
1,251
+2
+0.2% +$373 0.26% 64
2024
Q2 		$214K Buy
1,249
+1
+0.1% +$166 0.25% 64
2024
Q1 		$227K Buy
+1,248
New +$215K 0.29% 53
2023
Q2 		– Sell
-1,274
Closed -$206K – 49
2023
Q1 		$206K Buy
1,274
+34
+3% +$5.2K 0.37% 47
2022
Q4 		$200K Buy
+1,240
New +$190K 0.38% 44
2022
Q2 		– Sell
-1,236
Closed -$200K – 48
2022
Q1 		$200K Buy
+1,236
New +$180K 0.3% 51

Other funds holding ABBV

Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
ZWJ Investment Counsel
ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Boyce & Associates Wealth Consulting's ABBV Position: Q3 2026 in Review

Boyce & Associates Wealth Consulting increased its AbbVie (ABBV) stake by 0.07% in Q3 2026, buying an estimated $256 and bringing the position to 1,396 shares worth $365K. The position accounts for 0.22% of the portfolio, ranked #60.

Boyce & Associates Wealth Consulting first reported a position in ABBV in Q1 2022 and has held it in 14 quarters since. 564 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Boyce & Associates Wealth Consulting held 1,396 shares of AbbVie worth $365K as of Q3 2026.
  • Boyce & Associates Wealth Consulting bought 1 AbbVie share in Q3 2026, an estimated $256.
  • AbbVie made up 0.22% of Boyce & Associates Wealth Consulting's portfolio in Q3 2026, its #60 holding.
  • Boyce & Associates Wealth Consulting first reported a position in AbbVie in Q1 2022 and has held it in 14 quarters since.
  • 564 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Boyce & Associates Wealth Consulting's 13F filing for Q3 2026, filed 14 Oct 2026.